Common Contracts
10 similar License, Development and Commercialization Agreement contracts by Molecular Insight Pharmaceuticals, Inc., Myogen Inc, Corixa Corp, others
BACKGROUNDLicense, Development and Commercialization Agreement • January 30th, 2007 • Molecular Insight Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
BACKGROUNDLicense, Development and Commercialization Agreement • January 22nd, 2007 • Molecular Insight Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
AGREEMENT by and between HYBRIDON, INC. andLicense, Development and Commercialization Agreement • August 9th, 2005 • Hybridon Inc • Biological products, (no disgnostic substances) • New York
EXHIBIT 10.3 CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. ASTERISKS DENOTE OMISSIONS. LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT BY AND BETWEEN MILLENNIUM PHARMACEUTICALS, INC.License, Development and Commercialization Agreement • August 4th, 2004 • Millennium Pharmaceuticals Inc • Pharmaceutical preparations • New York
INTRODUCTIONLicense, Development and Commercialization Agreement • October 28th, 2003 • Myogen Inc • Pharmaceutical preparations • Massachusetts
INTRODUCTIONLicense, Development and Commercialization Agreement • October 9th, 2003 • Myogen Inc • Pharmaceutical preparations • Massachusetts
Exhibit 10.37 * The asterisk denotes that confidential portions of this exhibit have been omitted in reliance on Rule 24b-2 of the Securities Exchange Act of 1934. The confidential portions have been submitted separately to the Securities and Exchange...License, Development and Commercialization Agreement • May 15th, 2003 • Guilford Pharmaceuticals Inc • Pharmaceutical preparations • New York
ANDLicense, Development and Commercialization Agreement • December 5th, 2002 • Corixa Corp • Biological products, (no disgnostic substances) • Washington
EXHIBIT 10.1 LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENTLicense, Development and Commercialization Agreement • November 13th, 2002 • Genaera Corp • Biological products, (no disgnostic substances)
EXHIBIT 10.1 VERTEX PHARMACEUTICALS INCORPORATED HAS OMITTED FROM THIS EXHIBIT 10.1 PORTIONS OF THE AGREEMENT FOR WHICH THE COMPANY HAS REQUESTED CONFIDENTIAL TREATMENT FROM THE SECURITIES AND EXCHANGE COMMISSION. THE PORTIONS OF THIS EXHIBIT FOR...License, Development and Commercialization Agreement • November 15th, 1999 • Vertex Pharmaceuticals Inc / Ma • Pharmaceutical preparations • Delaware
